The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease

By Kordelas Lambros   Steckel Nina-Kristin   Horn Peter A.   Beelen Dietrich W.   Rebmann Vera  

International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-10 ,pp. : 1797-1797

MDPI

Access to resources Recommend Favorite

HLA-C KIR-Ligands Determine the Impact of Anti-Thymocyte Globulin (ATG) on Graft versus Host and Graft versus Leukemia Effects Following Hematopoietic Stem Cell Transplantation

By Clausen Johannes   Böhm Alexandra   Straßl Irene   Stiefel Olga   Buxhofer-Ausch Veronika   Machherndl-Spandl Sigrid   König Josef   Schmidt Stefan   Steitzer Hansjörg   Danzer Martin   Kasparu Hedwig   Weltermann Ansgar   Nachbaur David  

Biomedicines, Vol. 5, Iss. 2, 2017-03 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

By Villa Nancy Y.   Rahman Masmudur M.   McFadden Grant   Cogle Christopher R.  

Viruses, Vol. 8, Iss. 3, 2016-03 ,pp. : 85-85

MDPI

Access to resources Recommend Favorite

Exploiting Cell Death Pathways for Inducible Cell Elimination to Modulate Graft-versus-Host-Disease

By Falcon Corey   AL-Obaidi Mustafa   Di Stasi Antonio  

Biomedicines, Vol. 5, Iss. 2, 2017-06 ,pp. : 30-30

MDPI

Access to resources Recommend Favorite

Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease

By McGuirk Joseph P.   Smith J. Robert   Divine Clint L.   Zuniga Micheal   Weiss Mark L.  

Pharmaceuticals, Vol. 8, Iss. 2, 2015-04 ,pp. : 196-220

MDPI

Access to resources Recommend Favorite